Sumitomo Mitsui Financial Group Inc. decreased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 50.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 471,846 shares of the financial services provider's stock after selling 471,846 shares during the period. CME Group makes up approximately 2.2% of Sumitomo Mitsui Financial Group Inc.'s holdings, making the stock its 8th largest position. Sumitomo Mitsui Financial Group Inc. owned approximately 0.13% of CME Group worth $123,614,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in CME. Ilmarinen Mutual Pension Insurance Co lifted its holdings in shares of CME Group by 29.8% in the 3rd quarter. Ilmarinen Mutual Pension Insurance Co now owns 94,238 shares of the financial services provider's stock valued at $24,688,000 after buying an additional 21,627 shares during the period. E Fund Management Hong Kong Co. Ltd. increased its stake in shares of CME Group by 7,833.3% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 238 shares of the financial services provider's stock worth $62,000 after purchasing an additional 235 shares in the last quarter. Sumitomo Life Insurance Co. raised its holdings in shares of CME Group by 2.3% in the third quarter. Sumitomo Life Insurance Co. now owns 56,333 shares of the financial services provider's stock worth $14,758,000 after acquiring an additional 1,268 shares during the last quarter. Mayflower Financial Advisors LLC lifted its holdings in CME Group by 0.7% in the 3rd quarter. Mayflower Financial Advisors LLC now owns 8,042 shares of the financial services provider's stock valued at $2,107,000 after purchasing an additional 55 shares in the last quarter. Finally, Advisors Asset Management Inc. acquired a new stake in CME Group during the third quarter worth approximately $1,675,000. Institutional investors and hedge funds own 87.75% of the company's stock.
More CME Group News
Here's some of the latest news about CME:
- Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
- Positive Sentiment: The company announced the first trade in its wind power contracts, extending its product lineup and potentially opening another market for trading and risk management. Article
- Neutral Sentiment: A report highlights exchange operators’ potential exposure to AI-driven trading, but provides no specific new CME business or financial update. Article
CME Group Trading Up 0.4%
NASDAQ CME opened at $307.54 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $110.08 billion, a price-to-earnings ratio of 25.23, a PEG ratio of 3.90 and a beta of 0.15. The firm's 50 day moving average price is $289.43 and its two-hundred day moving average price is $282.08. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, beating analysts' consensus estimates of $2.99 by $0.03. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The firm's revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm posted $2.68 earnings per share. Equities analysts anticipate that CME Group Inc. will post 12.36 EPS for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a $1.30 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group's dividend payout ratio (DPR) is currently 42.66%.
Insiders Place Their Bets
In related news, insider Sunil Cutinho sold 5,000 shares of the stock in a transaction dated Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total value of $1,493,500.00. Following the completion of the sale, the insider owned 20,037 shares in the company, valued at approximately $5,985,051.90. This trade represents a 19.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Julie Winkler sold 10,079 shares of the business's stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $305.15, for a total value of $3,075,606.85. Following the sale, the insider owned 21,482 shares in the company, valued at approximately $6,555,232.30. This represents a 31.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 61,166 shares of company stock valued at $18,276,512 in the last ninety days. Company insiders own 0.30% of the company's stock.
Wall Street Analyst Weigh In
CME has been the topic of a number of recent analyst reports. TD Cowen increased their price target on shares of CME Group from $292.00 to $300.00 and gave the stock a "buy" rating in a research note on Monday, October 5th. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a research report on Saturday, October 31st. Wells Fargo & Company boosted their price target on CME Group from $315.00 to $333.00 and gave the company an "overweight" rating in a report on Thursday, October 22nd. CLSA set a $367.00 target price on CME Group in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. upgraded shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 target price for the company in a research report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $314.44.
Check Out Our Latest Report on CME Group
CME Group Profile
(
Free Report)
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Featured Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.